Philippe Ancian, Head of Molecular Immunology and Biomarkers, Transgene France
Julie Barnes, CEO, Abcodia
Katia Bassett, Scientist II, Translational Oncology, Geron Corporation
Sam Blackman, Director, Oncology Early Clinical Development, GSK
Martin Buechert, COO MRDAC, Magnetic Resonance Development and Application Center – Freiburg
Miriam Dwek, Senior Lecturer in Biochemistry, Group Leader - Against Breast Cancer Research Unit. Dept of Molecular and Applied Biosciences, University of Westminster
Yasuhiro Funahashi, Senior Director, Scientific Affairs, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems
Garett Hampton, Senior Director Oncology Biomarkers Genentech
Heidi Lane, Head of Cancer Biology, Basilea Pharmaceutica International Ltd
Magnus Nord, Associate Professor, Safety Science Physician, Patient Safety, AstraZeneca R&D
Maria Orr, Diagnostic Team Director, Personalised Healthcare and Biomarkers, AstraZeneca
Costantino Pitzalis, Professor of Experimental Rheumatology, Barts and the London NHS Trust
Senior Representative, QIAGEN
Senior Representative, Crown Bioscience
Karol Sikora, Professor, Dean School of Medicine, Buckingham University, & Medical Director, Cancer Partners